CVS Health raises 2026 guidance, shares trade in S&P 500 healthcare mix
25.06.2026 - 20:41:45 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-25, 20:41.
CVS Health Corp. (US1266501006) underlines a stronger 2026 outlook after reporting a solid first quarter and updating guidance on its NYSE listing, which is part of the S&P 500 healthcare cohort.The company details the guidance raise and Q1 results on its IR site.
The group also spotlights fresh foundation grants and pharmacy initiatives that sit alongside the core retail and insurance businesses.
What CVS Health reported
CVS Health states on its investor relations page that first quarter 2026 results were strong and that full-year 2026 guidance was raised, indicating improved expectations for key earnings metrics compared with earlier targets.The Q1 2026 results and guidance update are summarized in the company’s investor materials.
The company notes that performance across its health services, pharmacy and insurance operations contributed to the updated outlook, reflecting the diversified revenue base.
Community grants and GLP-1 support
On June 25, 2026, the CVS Health Foundation announced investments of $1 million into Hartford nonprofits and $1 million into Rhode Island nonprofits, focusing on community health needs such as access to care and local health programs.A PRNewswire release highlights the Hartford grantsand a companion release covers the Rhode Island commitments.
Earlier in the week, CVS Pharmacy reported an expansion of GLP-1 medication support services aimed at lowering costs, improving access and helping patients stay on therapy, underscoring the group’s role in chronic disease management.The GLP-1 support expansion is outlined in a CVS Pharmacy press statement.
All news and analysis on the CVS Health shares
Further articles, data and background on CVS Health and its stock performance are available in the dedicated topic section and via the company’s investor relations hub.
The business behind CVS Health
CVS Health’s business combines retail pharmacy operations, pharmacy benefit management and health insurance services anchored by its Aetna unit, creating a vertically integrated health solutions model.The company’s description outlines its health solutions strategy.
A representative product offering is CVS Pharmacy’s prescription fulfillment and medication counseling platform, which is complemented by walk-in MinuteClinic services and digital tools that link pharmacy data with insurance coverage.
Where the CVS Health stock trades today
CVS Health Corp. (US1266501006) shares trade on the NYSE under the ticker CVS, with the stock also tracked on European platforms where the latest available reference shows around 89 to 90 euros in indicative pricing for the US listing.
As of 2026-06-25, 20:41, CVS Health shares are most closely followed via their NYSE price in US dollars, with delayed quote information available on the company’s investor page and major financial data services.
CVS Health in key figures
- Company: CVS Health Corporation
- ISIN: US1266501006
- WKN: 859034
- Ticker: CVS
- Trading venue: NYSE
- Price (as of 2026-06-25, 20:41): 104.37 USD
- Market cap: approximately 130 billion USD (as of late June 2026, based on public market data)
- Sector / industry: Health Care Providers & Services
- Index membership: S&P 500
- Next earnings date: 2026-08-06
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a buy or sell recommendation, or a solicitation to trade CVS Health shares or any other securities.
